HF
IMCR icon

HRT Financial’s Immunocore IMCR Stock Holding History

HRT Financial’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.8M Buy
56,787
+33,926
+148% +$1M ﹤0.01% 1814
2026
Q1 		$689K Sell
22,861
-9,735
-30% -$315K ﹤0.01% 2299
2025
Q4 		$1.13M Buy
32,596
+23,800
+271% +$840K ﹤0.01% 1644
2025
Q3 		$319K Sell
8,796
-6,248
-42% -$212K ﹤0.01% 2132
2025
Q2 		$472K Buy
+15,044
New +$467K ﹤0.01% 1633
2024
Q4 		– Sell
-6,479
Closed -$201K – 2795
2024
Q3 		$201K Buy
+6,479
New +$236K ﹤0.01% 1974
2024
Q1 		– Sell
-20,921
Closed -$1.43M – 2652
2023
Q4 		$1.43M Buy
20,921
+7,639
+58% +$397K 0.01% 815
2023
Q3 		$689K Buy
+13,282
New +$786K 0.01% 1219

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

HRT Financial's IMCR Position: Q2 2026 in Review

HRT Financial increased its Immunocore (IMCR) stake by 148% in Q2 2026, buying an estimated $1M and bringing the position to 56,787 shares worth $1.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1814.

HRT Financial first reported a position in IMCR in Q3 2023 and has held it in 8 quarters since. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • HRT Financial held 56,787 shares of Immunocore worth $1.8M as of Q2 2026.
  • HRT Financial bought 33,926 Immunocore shares in Q2 2026, an estimated $1M.
  • Immunocore made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #1814 holding.
  • HRT Financial first reported a position in Immunocore in Q3 2023 and has held it in 8 quarters since.
  • 135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.